Zobrazeno 1 - 10
of 99
pro vyhledávání: '"Frank I, Lin"'
Autor:
Fahmida Haque, Jorge A. Carrasquillo, Evrim B. Turkbey, Esther Mena, Liza Lindenberg, Philip C. Eclarinal, Naris Nilubol, Peter L. Choyke, Charalampos S. Floudas, Frank I. Lin, Baris Turkbey, Stephanie A. Harmon
Publikováno v:
EJNMMI Research, Vol 14, Iss 1, Pp 1-11 (2024)
Abstract Background Somatostatin receptor (SSR) targeting radiotracer 68Ga-DOTATATE is used for Positron Emission Tomography (PET)/Computed Tomography (CT) imaging to assess patients with Pheochromocytoma and paraganglioma (PPGL), rare types of Neuro
Externí odkaz:
https://doaj.org/article/f6d4fa2f244541868489f1434571e4ca
Autor:
Briana N. Cortez, Mickey J. M. Kuo, Abhishek Jha, Mayank Patel, Jorge A. Carrasquillo, Tamara Prodanov, Kailah M. Charles, Sara Talvacchio, Alberta Derkyi, Frank I. Lin, David Taïeb, Jaydira Del Rivero, Karel Pacak
Publikováno v:
Frontiers in Endocrinology, Vol 15 (2024)
Few reports have highlighted the rare presence of somatic ATRX variants in clinically aggressive, metastatic pheochromocytoma/paraganglioma (PCC/PGL); however, none have addressed detailed clinical presentation (including biochemistry and imaging) an
Externí odkaz:
https://doaj.org/article/24454dee70a44c98a12a8b2e8affd5e7
Autor:
Bruna Fernandes, Jyoti Roy, Falguni Basuli, Blake M. Warner, Liza Lindenberg, Esther Mena, Steven S. Adler, Gary L. Griffiths, Peter L. Choyke, Frank I. Lin
Publikováno v:
Frontiers in Oncology, Vol 14 (2024)
IntroductionProstate-specific membrane antigen (PSMA) is present in high amounts in salivary glands, but it is unclear whether labeled binders of PSMA are excreted in the saliva.MethodsTen patients with prostate cancer underwent whole-body [18F]DCFPy
Externí odkaz:
https://doaj.org/article/f3c04f51e69141feadf741b9a05d20a5
Autor:
Sriram Gubbi, Mohammad Al-Jundi, Sungyoung Auh, Abhishek Jha, Joy Zou, Inna Shamis, Leah Meuter, Marianne Knue, Baris Turkbey, Liza Lindenberg, Esther Mena, Jorge A. Carrasquillo, Yating Teng, Karel Pacak, Joanna Klubo-Gwiezdzinska, Jaydira Del Rivero, Frank I. Lin
Publikováno v:
Frontiers in Endocrinology, Vol 14 (2023)
PurposeWhile there are reports of treatment-related endocrine disruptions and catecholamine surges in pheochromocytoma/paraganglioma (PPGL) patients treated with [177Lu]Lu-DOTA-TATE therapy, the spectrum of these abnormalities in the immediate post-t
Externí odkaz:
https://doaj.org/article/1a998faee69e4db693e7b0732be92100
Autor:
Jyoti Roy, Blake M. Warner, Falguni Basuli, Xiang Zhang, Changyu Zheng, Corrine Goldsmith, Tim Phelps, Karen Wong, Anita T. Ton, Rick Pieschl, Margaret E. White, Rolf Swenson, John A. Chiorini, Peter L. Choyke, Frank I. Lin
Publikováno v:
EJNMMI Research, Vol 11, Iss 1, Pp 1-11 (2021)
Abstract Background PSMA-targeted radionuclide therapy (TRT) is a promising treatment for prostate cancer (PCa), but dose-limiting xerostomia can severely limit its clinical adaptation, especially when using alpha-emitting radionuclides. With [18F]DC
Externí odkaz:
https://doaj.org/article/cca22949d8694e11bdc75a8355c78adb
Autor:
Sanjiv S. Gambhir, May Han, Venkataraman Sriram, Jason Karamchandani, Frank I. Lin, Hua Fan-Minogue, Erik S. Mittra
Supplementary Tables - PDF file 86K, Supplementary Table 1. Overall results of 2nd experiment shown as percent change from baseline by experimental group: Control, Low Dose, and High Dose. Supplementary Table 2. Mitotic activity and Ki-67 labeling in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::412b709cfb42c5d57b6a52df832fffad
https://doi.org/10.1158/1078-0432.22448541.v1
https://doi.org/10.1158/1078-0432.22448541.v1
Autor:
Sanjiv S. Gambhir, May Han, Venkataraman Sriram, Jason Karamchandani, Frank I. Lin, Hua Fan-Minogue, Erik S. Mittra
Supplementary Figures - PDF file 110K, Supplementary Figure 1. Dose titration curves of ficlatuzumab. The numbers in parenthesis are the median survival in days. Supplementary Figure 2. combination therapy of ficlatuzumab and temozolomide studied in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a98790e186d692bf93cdbc2f567dacd9
https://doi.org/10.1158/1078-0432.22448544.v1
https://doi.org/10.1158/1078-0432.22448544.v1
Autor:
Sanjiv S. Gambhir, May Han, Venkataraman Sriram, Jason Karamchandani, Frank I. Lin, Hua Fan-Minogue, Erik S. Mittra
Supplementary Figure Legend - PDF file 60K, Supplementary figure legend
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::188b983cdc5a14cd8357fe6c5bd7af06
https://doi.org/10.1158/1078-0432.22448547.v1
https://doi.org/10.1158/1078-0432.22448547.v1
Autor:
Sanjiv S. Gambhir, May Han, Venkataraman Sriram, Jason Karamchandani, Frank I. Lin, Hua Fan-Minogue, Erik S. Mittra
Purpose: Ficlatuzumab is a novel therapeutic agent targeting the hepatocyte growth factor (HGF)/c-MET pathway. We summarize extensive preclinical work using this agent in a mouse brain orthotopic model of glioblastoma.Experimental Design: Sequential
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2133c66cc52d64ae35c06def640cec31
https://doi.org/10.1158/1078-0432.c.6521421
https://doi.org/10.1158/1078-0432.c.6521421
Autor:
Abhishek Jha, Mayank Patel, Alexander Ling, Clara C. Chen, Corina Millo, Kailah Charles, Sara Talvacchio, Josephine Ezemobi, Peter Herscovitch, Frank I. Lin, Naris Nilubol, David Taieb, Civelek Ali Cahid, Jorge Carrasquillo, Karel Pacak
Publikováno v:
Endocrine Abstracts.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f4dc5b8568b1d20ce19867309026bda7
https://doi.org/10.1530/endoabs.89.c28
https://doi.org/10.1530/endoabs.89.c28